- NeuroQuant® Brain Tumor
FDA-cleared software for advanced brain tumor analyses
Automated Brain Tumor Segmentation
Benefits
High- and low-grade glioma
Slice by slice tumor segmentation in DICOM format
Longitudinal disease assessment
Automated quantification and tracking of pre- and post-treatment brain tumor volumes across time
Clinical trial support
Objective tumor quantification for improved confidence and efficiency
Unique microstructure insights
Patented Restriction Spectrum Imaging (RSI) advanced diffusion technology
NeuroQuant® Brain Tumor report
Comprehensive segmentation and volumetrics reporting, automatically routed to PACS.
The NeuroQuant® Brain Tumor Report
Provides tumor boards with a time series of brain tumor volume analysis across scans. 3D volumetrics are displayed for tumor ROIs that enable more efficient and objective reviews.
The NeuroQuant® Brain Tumor Report
Provides tumor boards with a time series of brain tumor volume analysis across scans. 3D volumetrics are displayed for tumor ROIs that enable more efficient and objective reviews.
Understanding CPT Codes 0865T & 0866T
As of January 1, 2024, new Category III CPT codes (0865T, 0866T) are active for AI-assisted quantitative brain MRI analysis. These codes apply to a variety of vendor solutions, including Cortechs.ai, and serve as an essential step toward achieving permanent reimbursement.
